• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD ACETLR CUP HAP 58MM W/ IMPTR; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD ACETLR CUP HAP 58MM W/ IMPTR; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING Back to Search Results
Catalog Number 74120158
Device Problem Biocompatibility (2886)
Patient Problems Pain (1994); Unspecified Mental, Emotional or Behavioural Problem (4430); Metal Related Pathology (4530); Insufficient Information (4580)
Event Date 08/10/2022
Event Type  Injury  
Event Description
Us legal: it is reported that, after bhr-tha on (b)(6) 2010, the plaintiff has suffered from metallosis and multi-system reaction which has caused him pain and mental anguish.Plaintiff underwent revision surgery on an unknown date.The patient's current health status is unknown.
 
Manufacturer Narrative
Internal complaint reference: (b)(4).
 
Manufacturer Narrative
It was reported that revision surgery was performed on the patient¿s hip.As of today, the devices used in treatment have been requested but have not become available.Without definitive lot numbers, a complete complaint history review cannot be performed for the devices involved.As no device batch numbers were provided for investigation, a manufacturing record review, device labelling and ifu review could not be performed.A risk management review was performed for the cup.No additional risks were identified as result of the reported event.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.A risk management review could not be performed for the hemi head as it has been phased out the market, therefore there is no live risk management file to review for the head.The available medical information was reviewed.Based on the reported symptoms it cannot be concluded that the events/clinical reactions (pain and metal debris) were associated with a mal-performance of the implant.The patient impact cannot be determined at this time.Without return of the actual devices or further information we cannot further investigate or confirm the reported complaint.The investigation remains inconclusive and a definitive root cause cannot be determined.Additionally, specific factors known to contribute to the alleged fault cannot be provided due to the insufficient information.If the products or additional information become available in the future, this case will be reopened.Based on the results of this investigation, the need for corrective or preventative action is not indicated.
 
Manufacturer Narrative
Additional information: b6 (metal ion levels in blood added).Corrected data: b3, h6 (health effect - clinical code and health effect - impact code).
 
Manufacturer Narrative
It was reported that after bhr total hip arthroplasty, the plaintiff has suffered from metallosis and multi-system reaction which has caused him pain and mental anguish.As of today, the implanted devices, all of which were used in treatment have not been returned for evaluation.As no device part and batch numbers were provided for investigation, a complaint history review, manufacturing record review, or escalation actions review could not be performed.If more information is received, this investigation will be reopened.The review of the product's current instructions for use found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed for the bhr acetabular cup.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.The available medical documents were reviewed.Based on the reported symptoms it cannot be concluded that the events/clinical reactions (pain and metal debris) were associated with a mal-performance of the implant.The patient impact cannot be determined at this time.Based on the information provided we cannot further investigate the reported complaint, our investigation remains inconclusive, and a definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement, loosening of components may increase production of wear particles and accelerate damage to the bone.Should the devices or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.
 
Manufacturer Narrative
H3, h6: it is reported that right hip revision surgery was performed due to metallosis and a multi-system reaction, which caused the patient pain and mental anguish.A blood test result revealed a chromium level in serum of 4 ng/ml and a cobalt level in serum of 10.6 ng/ml.As of today, the implanted devices, all of which were used in treatment, have not been returned for evaluation.As no device part and batch numbers were provided for investigation, a complaint history review, manufacturing record review, or escalation actions review could not be performed.If more information is received, these tasks will be reevaluated.A review of the product's current ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review found that the alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.With the limited information provided the clinical root cause of the reported elevated cobalt and reported pain, metallosis and multi-system reaction cannot be confirmed.It cannot be concluded the reported events/clinical reactions were associated with a mal-performance of the implant or an implant failure.The patient impact beyond the reported pain, revision and post operative convalescence period cannot be determined with the limited information provided.Based on the information provided we cannot further investigate the reported complaint, our investigation remains inconclusive, and a definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement, loosening of components may increase production of wear particles and accelerate damage to the bone.Should the devices or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.
 
Event Description
It is reported that, after a right bhr-tha had been performed on (b)(6) 2010, the patient has suffered from metallosis and multi-system reaction which has caused him pain and mental anguish.A blood test result performed on (b)(6) 2022 revealed a chromium level in serum of 4 ng/ml and a cobalt level in serum of 10.6 ng/ml.The patient underwent revision surgery on (b)(6) 2023.During the revision, the cup was well fixed with corrosion at the margins.There was deficient bone in the posterior wall.Also, there was corrosion and black material on the trunnion.A large amount of scar had to be removed from above and below the trunnion to allow mobilization.The patient's current health status is unknown.
 
Manufacturer Narrative
Additional information: b5-describe event or problem.B6-relevant tests/laboratory data.
 
Manufacturer Narrative
H3, h6: it is reported that right hip revision surgery was performed due to metallosis and a multi-system reaction, which caused the patient pain and mental anguish.A blood test result revealed a chromium level in serum of 4 ng/ml and a cobalt level in serum of 10.6 ng/ml.As of today, the implanted devices, all of which were used in treatment, have not been returned for evaluation.As no device part and batch numbers were provided for investigation, a complaint history review, manufacturing record review, or escalation actions review could not be performed.If more information is received, these tasks will be reevaluated.A review of the product's current ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review found that the alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.Although the reported pain, elevated cobalt, necrosis and corrosion may be consistent with the reported trunnionosis, with the information provided, the clinical root cause of the reported elevated cobalt and reported pain, metallosis and multi-system reaction cannot be confirmed.It cannot be concluded the reported events/clinical reactions were associated with a mal performance of the implant.The patient impact beyond the reported pain, revision and post operative convalescence period cannot be determined with the information provided.Four-weeks post-operative cobalt and chromium were 4.1 and 1.7 ng/ml respectively.Based on the information provided we cannot further investigate the reported complaint, our investigation remains inconclusive, and a definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement, loosening of components may increase production of wear particles and accelerate damage to the bone.Should the devices or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.
 
Manufacturer Narrative
H3, h6: it is reported that right hip revision surgery was performed due to metallosis and a multi-system reaction, which caused the patient pain and mental anguish.A blood test result revealed a chromium level in serum of 4 ng/ml and a cobalt level in serum of 10.6 ng/ml.As of today, the implanted devices, all of which were used in treatment, have not been returned for evaluation.As no device part and batch numbers were provided for investigation, a complaint history review, manufacturing record review, or escalation actions review could not be performed.If more information is received, these tasks will be reevaluated.A review of the product's current ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review found that the alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.Although the reported pain, elevated cobalt, necrosis and corrosion may be consistent with the reported trunnionosis, with the information provided, the clinical root cause of the reported elevated cobalt and reported pain, metallosis and multi-system reaction cannot be confirmed.It cannot be concluded the reported events/clinical reactions were associated with a mal performance of the implant.The patient impact beyond the reported pain, revision and post operative convalescence period cannot be determined with the information provided.Four-weeks post-operative cobalt and chromium were 4.1 and 1.7 ng/ml respectively.Based on the information provided we cannot further investigate the reported complaint, our investigation remains inconclusive, and a definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement, loosening of components may increase production of wear particles and accelerate damage to the bone.Should the devices or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.Additional information: a2, a4, b7, d6b, d10.Corrected data: e1 (reporter's name), g2, h6 (health effect - clinical code).
 
Manufacturer Narrative
H10- additional information.D4- unique identifier (udi) #, expiration date.D10- concomitant medical products.H4- device manufacture date h11- corrected data.B5- describe event or problem.D4- catalog number, lot number.
 
Event Description
It was reported that, after a right bhr-tha had been performed on (b)(6) 2010, the patient has suffered from metallosis and multi-system reaction which has caused him pain and mental anguish.A blood test result performed on (b)(6) 2022 revealed a chromium level in serum of 4 ng/ml and a cobalt level in serum of 10.6 ng/ml, for which the patient underwent revision surgery on (b)(6) 2023.During this procedure, the femoral stem was found to be well-fixed.Corrosion and black material was noted on the trunnion, which was cleaned and subsequently found to be undamaged.The acetabular cup, hemi-head and modular sleeve were removed and replaced with a competitor's construct (zimmer-biomet).The patient was discharged to the recovery room in stable condition.
 
Manufacturer Narrative
Corrected data: b6 (test results).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACETLR CUP HAP 58MM W/ IMPTR
Type of Device
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK  CV31 3HL
Manufacturer (Section G)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK   CV31 3HL
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key13896773
MDR Text Key288382102
Report Number3005975929-2022-00082
Device Sequence Number1
Product Code NXT
UDI-Device Identifier03596010502605
UDI-Public03596010502605
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 04/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/24/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2012
Device Catalogue Number74120158
Device Lot Number081682
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/29/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/30/2007
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ANTLGY SZ 9 STM: 71357009, 08LM09718A; HM HD 50MM: 74122550, 08HW18259; MLR SLV12/14: 74222200, 08JW19031; UNKN BIRMINGHAM HIP MODULAR HEAD (BHMH) SLEEVE
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age70 YR
Patient SexMale
Patient Weight73 KG
-
-